Mechanistically, chronic IL-17/TNF-α–driven inflammation promotes endothelial dysfunction, arterial stiffness, and pro-thrombotic pathways—biologic plausibility that aligns with higher MI/ACS rates in observational cohorts and contemporary reviews [41]. This evidence concerns the gene IL17A and endothelial dysfunction.